Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Med-Strategi cs AB
AB
Dissolved
Org 5566514856
Medical specialists activities
· NACE 8622
Est. 2003
1 employees
Watchlist
Share
Sweden
/
Companies
/
Medical specialists activities
/
Med-Strategi cs AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2024
Income statement
SEK thousands
Item
2021
2022
2023
2024
2024
Revenue
346
443
276
249
125
Staff expenses
—
−79
−17
−24
−0
EBITDA
38
239
146
125
27
Depreciation & amort.
−5
—
—
—
—
EBIT
33
239
146
125
27
Net financials
−27
—
0
−0
−0
Profit before tax
6
239
146
124
27
Tax
−3
−51
−31
−27
−6
Net profit
3
189
115
98
21
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2024
Total assets
275
525
364
282
203
Equity
124
313
238
218
141
Long-term debt
0
—
—
—
—
Short-term debt
151
212
126
64
61
Total debt
151
212
126
64
61
Financial ratios
5-year trend
EBITDA-margin
22.0%
This company
15.8%
Market median
+39% vs market
2021
2024
Soliditetsgrad
69.7%
This company
38.2%
Market median
+82% vs market
2021
2024
Egenkapitalforrentning
14.7%
This company
18.4%
Market median
+20% vs market
2021
2024
Nettoresultatgrad
16.7%
This company
8.1%
Market median
+106% vs market
2021
2024
Aktivomsætning
0.62×
This company
1.12×
Market median
-45% vs market
2021
2024
Gæld/egenkapital
0.44×
This company
0.62×
Market median
+29% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2024-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
View
PDF
More on Med-Strategi cs AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network